New Ray Medicine Expects Notable Loss Reduction

New Ray Medicine International Holding Ltd. (HK:6108) has released an update.

New Ray Medicine International Holding Ltd. anticipates a significant decrease in losses for the first half of 2024, with a projected net loss not exceeding HK$5.0 million, a substantial improvement from the HK$13.4 million loss in the same period of 2023. The improvement is attributed to reduced net exchange losses, lower impairment loss on receivables, and decreased marketing and delivery expenses. Investors are cautioned that these preliminary figures are subject to finalization and audit.

For further insights into HK:6108 stock, check out TipRanks’ Stock Analysis page.